Leptin signalling, obesity and prostate cancer: molecular and clinical perspective on the old dilemma

por Alshaker, Heba, Sacco, Keith, Alfraidi, Albandri, Muhammad, Aun, Winkler, Mathias, Pchejetski, Dmitri
Publicado no Oncotarget (2015)

Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer

por Pchejetski, Dmitri, Alfraidi, Albandri, Sacco, Keith, Alshaker, Heba, Muhammad, Aun, Monzon, Leonardo
Publicado no J Cancer Res Clin Oncol (2015)

HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer

por Stronach, Euan A, Alfraidi, Albandri, Rama, Nona, Datler, Christoph, Studd, Jamie, Agarwal, Roshan, Guney, Tankut G, Gourley, Charlie, Hennessy, Bryan T, Mills, Gordon B, Mai, Antonello, Brown, Robert, Dina, Roberto, Gabra, Hani
Publicado em 2011

A novel compound ARN-3236 inhibits Salt Inducible Kinase 2 and sensitizes ovarian cancer cell lines and xenografts to paclitaxel

por Zhou, Jinhua, Alfraidi, Albandri, Zhang, Shu, Santiago-O’Farrill, Janice M., Yerramreddy, Venkata Krishna Reddy, Alsaadi, Abdulkhaliq, Ahmed, Ahmed A., Yang, Hailing, Liu, Jinsong, Mao, Weiqun, Wang, Yan, Takemori, Hiroshi, Vankayalapati, Hariprasad, Lu, Zhen, Bast, Robert C.
Publicado no Clin Cancer Res (2016)